PubMed Health⌕ Search

Biomedical subjects

M C Asselin

Publications and source records attributed to M C Asselin.

7 recordsLinked to original sources
PubMed2000

Equilibration of 6-[18F]fluoro-L-m-tyrosine between plasma and erythrocytes.

UNLABELLED: Intracranial or intraventricular blood pools have been suggested as noninvasive sources of an input function for quantitative PET. These techniques measure the concentration of the tracer in whole blood, but the concentration in plasma depends on the equilibration of the tracer between plasma and erythrocytes. METHODS: FDG, 6-[18F]fluoro-L-m-tyrosine (FmT), or its major metabolite, 6-[18F]fluoro-3-hydroxyphenylacetic acid (FHPAA), was added to blood samples obtained from healthy fasting volunteers along with radioiodinated human serum albumin (RIHSA). Samples were incubated at 37 degrees C for times between 10 s and 2 h and then plunged into an ice bath and centrifuged. Whole blood and plasma were counted for 18F and 125I activities. The resulting time courses were fit to successively more complex models, evaluated using an F test. RESULTS: All radioactivity associated with RIHSA remained in the plasma, whereas FDG equilibrated instantaneously between plasma and erythrocytes. FmT took about 1 h to equilibrate between plasma and erythrocytes; this time course could be described by a single exponential with a half-life of 10 min. FHPAA equilibrated within the first 5 min of the study. CONCLUSION: Our results show that, unlike FDG, the partitioning of FmT between plasma and erythrocytes is a relatively slow process. We present an analytic correction that may be applied to the measured time course of radioactivity in whole blood to obtain the time course of the tracer in plasma.

Erythrocytes↗
PubMed1999

Regions of interest in the venous sinuses as input functions for quantitative PET.

UNLABELLED: As clinical PET becomes increasingly available, quantitative methods that are feasible in busy clinical settings are becoming necessary. We investigated the use of intracranial blood pools as sources of an input function for quantitative PET. METHODS: We studied 25 patients after the intravenous injection of [18F]6-fluoro-L-m-tyrosine and compared sampled blood time-activity curves with those obtained in small regions of interest (ROIs) defined in the blood pools visible in the PET images. Because of the comparatively large dimensions of the blood pool at the confluence of the superior sagittal, straight and transverse sinuses, a venous ROI input function was chosen for further analysis. We applied simple corrections to the ROI-derived time-activity curves, deriving expressions for partial volume, spillover and partition of tracer between plasma and red blood cells. The results of graphic and compartmental analysis using both sampled [Cs(t)] and ROI [Cr(t)] venous input functions for each patient were compared. We also used an analytic approach to examine possible differences between venous and arterial input functions in the cerebral circulation. RESULTS: Cr(t) peaked significantly earlier and higher than Cs(t) in this patient population, although the total integral under the curves did not differ significantly. We report some apparent differences in the results of modeling using the two input functions; however, neither the graphically determined influx constant, Ki, nor the model parameter that reflects presynaptic dopaminergic metabolism, k3, differed significantly between the two methods. The analytic results suggest that the venous ROI input function may be closer to the arterial supply of radiotracer to the brain than arterialized venous blood, at least in some patient populations. CONCLUSION: We present a simple method of obtaining an input function for PET that is applicable to a wide range of tracers and quantitative methods and is feasible for diagnostic PET imaging.

Cerebrovascular Circulation↗
PubMed1998

Calretinin-immunoreactive neurons in the human thalamus.

The distribution of the calcium-binding protein calretinin in the thalamus of normal human individuals was studied with immunohistochemistry. Calretinin immunoreactivity was weak in the geniculate bodies and in nuclei of the ventral and posterior groups, moderate in the reticular nucleus and in nuclei of the anterior, medial, and lateral groups, and strong in nuclei of the midline group and anterior intralaminar nuclei. The mediodorsal nucleus was unique among thalamic nuclei because it contained a wide variety of intensely immunostained perikarya embedded in a moderately-labelled neuropil. The reticular nucleus displayed several small and uniformly distributed neuronal clusters composed of immunostained perikarya lying in a moderately-labelled neuropil. Intense and uniform immunostaining was observed in all midline nuclei and in the anterior intralaminar nuclei, including the paracentral and central lateral nuclei. These nuclei, which harboured numerous intensely-stained perikarya lying in a dense immunoreactive neuropil, were the most strongly-immunoreactive structures of the entire human thalamus. At the level of the posterior intralaminar nuclei, the central median nucleus was virtually free of immunostaining whereas the parafascicular nucleus was moderately labelled. The nucleus submedius located just beneath the central median/parafascicular complex displayed a very intense calretinin immunostaining. This study has provided evidence for the presence of the protein calretinin in the human thalamus. The pattern of distribution of calretinin, as delineated in the present study, suggests that this calcium-binding protein may participate in various subcortical and cortical thalamic systems involved in the modulation of emotional and motivational states.

Aged↗
PubMed1996

Calretinin immunoreactivity in the thalamus of the squirrel monkey.

The distribution of the calcium-binding protein, calretinin, in the thalamus of the squirrel monkey (Saimiri sciureus) was studied with immunohistochemical methods. Calretinin was found to be heterogeneously distributed in the primate thalamus and to occur only in specific neuronal populations of certain thalamic nuclei. Neuronal cells and fibers in midline nuclei and their dorsolateral extension, which includes the parataenial and central superior lateral nuclei, displayed the most intense calretinin immunoreactivity. The immunoreactivity for cells and fibers in the intralaminar nuclei was moderate rostrally but very weak caudally. The centre mèdian nucleus, together with the medial habenular nucleus, were virtually devoid of calretinine immunostaining. The mediodorsal nucleus displayed a markedly heterogeneous staining, with numerous clusters of labeled cells and fibers in its central parvicellular part. Cell and fiber immunoreactivity ranged from moderate to high in the nuclei of the anterior and lateral groups, but was very weak in the nuclei of the ventral and posterior groups. There was a small to moderate number of heterogeneously distributed calretinin-immunoreactive cells and fibers in the lateral and medial geniculate bodies, as well as in the reticular nucleus. The present study provides the first evidence for the existence of calretinin in primate thalamus, where this protein is distributed according to a highly heterogeneous pattern. This specific pattern of distribution suggests that calretlnin may play a role that is complementary to those of the other calcium-binding proteins parvalbumin and calbindin D-28k in the thalamus of primates.

Animals↗
PubMed1994

Striatal changes in preproenkephalin mRNA levels in parkinsonian monkeys.

Levels of preproenkephalin (PPE) mRNA were measured in different sectors of the striatum with in situ hybridization histochemistry in both normal and parkinsonian (MPTP-treated) squirrel monkeys. In parkinsonian monkeys, a marked increase in PPE mRNA levels was noted in the dorsolateral third of the precommissural putamen and in most of the postcommissural putamen. These regions largely correspond to the sensorimotor striatal territory. The other striatal sectors, including the caudate nucleus, did not exhibit significant changes, despite the fact that the loss of the dopaminergic input was severe in most of the striatum. These results reveal that PPE mRNA expression is specifically altered in striatal regions involved in sensorimotor processing in parkinsonian monkeys.

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine↗